Smiths Medical gets FDA clearance for latest CADD-Solis pain management system

6 January 2014 (Last Updated January 6th, 2014 06:30)

Smiths Medical has obtained the US Food and Drug Administration (FDA) 510(k) clearance to market its CADD-Solis pain management system version 3.0 with programmed intermittent bolus (PIB) and patient controlled analgesics (PCA) delivery.

Smiths Medical

Smiths Medical has obtained the US Food and Drug Administration (FDA) 510(k) clearance to market its CADD-Solis pain management system version 3.0 with programmed intermittent bolus (PIB) and patient controlled analgesics (PCA) delivery.

This latest state-of-the-art CADD-Solis Ambulatory Infusion System is the first infusion pump to offer PIB delivery, combined with patient-controlled doses and continuous infusion in an integrated delivery system.

The new system is customised, easy-to-use and provides improved pain management. It also meets industry recognised standards for advanced error-reduction features in PCA pumps.

Epidural analgesia has earlier been provided to patients using a pump that delivers manual bolus injections from a clinician, continuous infusions, or intermittent doses of medication controlled by the patient.

However, these techniques may result in inconsistent and ineffective pain relief, as well as frequent clinician interventions. PIB medication delivery consists of programmed intermittent boluses that can be supplemented by patient-controlled doses.

"The PIB programming parameters and the delivery pressure provided by the CADD-Solis system offer flexible drug delivery and reliable distribution of medication, which can help overcome some of the challenges associated with epidural analgesia."

The system is designed to help healthcare professionals administer medication accurately, monitor a patient's response to therapy, stimulate early clinical assessment and facilitate patient recovery.

The CADD-Solis pump and CADD-Solis medication safety software promote patient safety, patient care and future scalable connectivity that is designed to grow with clinical and technology needs.

The platform is designed for nurses, anaesthesiologists, pharmacists and other hospital personnel involved in pain management infusion therapy.

CADD Medication Cassette Reservoirs and CADD Administration Sets exclusive reservoirs and sets contain or connect to medication and fit securely onto CADD-Solis pumps to promote increased medication security. The pump with reservoirs can fit easily into a pouch so patients can be mobile during therapy.

Smiths Medical vice-president global product management Tommy Johns said: "The PIB programming parameters and the delivery pressure provided by the CADD-Solis system offer flexible drug delivery and reliable distribution of medication, which can help overcome some of the challenges associated with epidural analgesia."


Image: Smiths Medical receives FDA 510(k) clearance on solution for pain management with CADD-Solis pump. Photo: courtesy of Smiths Medical.